High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer

Buc, Emmanuel, Dubois, Damien, Sauvanet, Pierre, Raisch, Jennifer, Delmas, Julien, Darfeuille-Michaud, Arlette, Pezet, Denis, Bonnet, Richard·2013·PLoS ONE

Cited by (538)

Items 101–200 of 538

  1. Increased Epithelial Oxygenation Links Colitis to an Expansion of Tumorigenic Bacteria
    Stephanie A. Cevallos, Jee‐Yon Lee, Connor R. Tiffany, Austin J. Byndloss, Luana Johnston, Mariana Xavier Byndloss, Andreas J. Bäumler · 2019 · mBio
  2. Shining a Light on Colibactin Biology
    Michael W. Dougherty, Christian Jobin · 2021 · Toxins
  3. Intratumoral presence of the genotoxic gut bacteria pks+ E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer
    Jihoon Eric Joo, Yen Lin Chu, Peter Georgeson, Romy Walker, Khalid Mahmood, Mark Clendenning, Aaron L. Meyers, Julia Como, Sharelle L. Joseland, Susan Preston et al. · 2024 · British Journal of Cancer
  4. The Association of Microbiome Dysbiosis With Colorectal Cancer
    Artem Artemev, Sheetal Naik, Anastasia Pougno, Prasanna Honnavar, Nandan Maruti Shanbhag · 2022 · Cureus
  5. Klebsiella pneumoniae producing bacterial toxin colibactin as a risk of colorectal cancer development - A systematic review
    Nicol Straková, Kristýna Kořená, Renáta Karpíšková · 2021 · Toxicon
  6. Gut Symbionts from Distinct Hosts Exhibit Genotoxic Activity via Divergent Colibactin Biosynthesis Pathways
    Philipp Engel, Maria I. Vizcaino, Jason M. Crawford · 2014 · Applied and Environmental Microbiology
  7. Contribution of pks+ E. coli mutations to colorectal carcinogenesis
    Chen, Bingjie, Ramazzotti, Daniele, Heide, Timon, Spiteri, Inmaculada, Fernandez-Mateos, Javier, James, Chela, Magnani, Luca, Graham, Trevor A., Sottoriva, Andrea · 2023 · Nature Communications
  8. Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer
    Julie Véziant, Romain Villéger, Nicolas Barnich, Mathilde Bonnet · 2021 · Cancers
  9. Impact of CDT Toxin on Human Diseases
    Tiphanie Faïs, Julien Delmas, Arnaud Serres, Richard Bonnet, Guillaume Dalmasso · 2016 · Toxins
  10. Structure and bioactivity of colibactin
    Kevin M. Wernke, Mengzhao Xue, Alina Tirla, Chung Sub Kim, Jason M. Crawford, Seth B. Herzon · 2020 · Bioorganic & Medicinal Chemistry Letters
  11. Microbiota and Cancer: The Emerging Beneficial Role of Bifidobacteria in Cancer Immunotherapy
    Giulia Longhi, Douwe van Sinderen, Marco Ventura, Francesca Turroni · 2020 · Frontiers in Microbiology
  12. The Gut Microbiota: A Potential Gateway to Improved Health Outcomes in Breast Cancer Treatment and Survivorship
    Kara Sampsell, Desirée Hao, Raylene A. Reimer · 2020 · International Journal of Molecular Sciences
  13. Microbe-based therapies for colorectal cancer: Advantages and limitations
    Mοhd Saeed, Ambreen Shoaib, Raghuram Kandimalla, Shamama Javed, Ahmad Almatroudi, Ramesh C. Gupta, Farrukh Aqil · 2021 · Seminars in Cancer Biology
  14. Escherichia coli ClbS is a colibactin resistance protein
    Nadège Bossuet‐Greif, Damien Dubois, Claude R. Petit, Sophie Tronnet, Patricia Martín, Richard Bonnet, Éric Oswald, Jean‐Philippe Nougayrède · 2015 · Molecular Microbiology
  15. The influence of the microbiota on immune development, chronic inflammation, and cancer in the context of aging
    Taylor Tibbs, Lacey R. Lopez, Janelle C. Arthur · 2019 · Microbial Cell
  16. Cytolethal Distending Toxin Subunit B: A Review of Structure–Function Relationship
    Benoît J. Pons, Julien Vignard, Gladys Mirey · 2019 · Toxins
  17. Bacterial Genotoxin-Induced DNA Damage and Modulation of the Host Immune Microenvironment
    Océane C. B. Martin, Teresa Frisan · 2020 · Toxins
  18. Interleukin-22 drives nitric oxide-dependent DNA damage and dysplasia in a murine model of colitis-associated cancer
    Wang, C., Gong, G., Sheh, A., Muthupalani, S., Bryant, E.M., Puglisi, D.A., Holcombe, H., Conaway, E.A., Parry, N A P, Bakthavatchalu, V. et al. · 2017 · Mucosal Immunology
  19. Relationship between gut microbiota and colorectal cancer: Probiotics as a potential strategy for prevention
    Seung Yun Lee, Da Young Lee, Ji Hyeop Kang, Jae Hyeon Kim, Jae Won Jeong, Hyun Woo Kim, Dong Hoon Oh, Seung Hyeon Yoon, Sun Jin Hur · 2022 · Food Research International
  20. Reactivity of an Unusual Amidase May Explain Colibactin’s DNA Cross-Linking Activity
    Yindi Jiang, Alessia Stornetta, Peter W. Villalta, Matthew R. Wilson, Paul D. Boudreau, Li Zha, Silvia Balbo, Emily P. Balskus · 2019 · Journal of the American Chemical Society
  21. Prevalence of pks-positive Escherichia coli in Japanese patients with or without colorectal cancer
    Takayuki Shimpoh, Yoshihiro Hirata, Sozaburo Ihara, Nobumi Suzuki, Hiroto Kinoshita, Yoku Hayakawa, Yumiko Ota, Akiko Narita, Shuntaro Yoshida, Atsuo Yamada et al. · 2017 · Gut Pathogens
  22. Bacterial Signaling at the Intestinal Epithelial Interface in Inflammation and Cancer
    Olivia I. Coleman, Dirk Haller · 2018 · Frontiers in Immunology
  23. Association of colorectal cancer with pathogenicEscherichia coli: Focus on mechanisms using optical imaging
    Julie Véziant, Johan Gagnière, E. Jouberton, Virginie Bonnin, Pierre Sauvanet, Denis Pezet, Nicolas Barnich, Elisabeth Miot‐Noirault, Mathilde Bonnet · 2016 · World Journal of Clinical Oncology
  24. Impact of microbiota in colorectal carcinogenesis: lessons from experimental models
    Linda Chia‐Hui Yu, Shu‐Chen Wei, Yen‐Hsuan Ni · 2018 · Intestinal Research
  25. Gut Microbiota and Colon Cancer: A Role for Bacterial Protein Toxins?
    Carla Fiorentini, Francesca Carlini, Elena Angela Pia Germinario, Zaira Maroccia, Sara Travaglione, Alessia Fabbri · 2020 · International Journal of Molecular Sciences
  26. Characterization of Polyketide Synthase Machinery from the pks Island Facilitates Isolation of a Candidate Precolibactin
    Li Zha, Matthew R. Wilson, Carolyn A. Brotherton, Emily P. Balskus · 2016 · ACS Chemical Biology
  27. Cellular metabolism in colorectal carcinogenesis: Influence of lifestyle, gut microbiome and metabolic pathways
    Hanne Røland Hagland, Kjetil Søreide · 2014 · Cancer Letters
  28. Early settlers: which<i>E. coli</i>strains do you not want at birth?
    Secher, Thomas, Brehin, Camille, Oswald, Eric · 2016 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  29. The Polyamine Spermidine Modulates the Production of the Bacterial Genotoxin Colibactin
    Camille V. Chagneau, Christophe Garcie, Nadège Bossuet‐Greif, Sophie Tronnet, Alexander O. Brachmann, Jörn Piel, Jean‐Philippe Nougayrède, Patricia Martín, Éric Oswald · 2019 · mSphere
  30. Convergent and Modular Synthesis of Candidate Precolibactins. Structural Revision of Precolibactin A
    Alan R. Healy, Maria I. Vizcaino, Jason M. Crawford, Seth B. Herzon · 2016 · Journal of the American Chemical Society
  31. The relationship between gastrointestinal cancers and the microbiota
    Kaitlyn D. LaCourse, Christopher D. Johnston, Susan Bullman · 2021 · The Lancet. Gastroenterology & hepatology
  32. Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences
    Sofia C. Tortora, Vimal Bodiwala, Andrew Quinn, Laura A. Martello, Shivakumar Vignesh · 2022 · World Journal of Gastrointestinal Oncology
  33. Gut Microbiota Signatures in Colorectal Cancer as a Potential Diagnostic Biomarker in the Future: A Systematic Review
    Lucian-Flavius Herlo, Andreea Sălcudean, Roxana Șirli, Stela Iurciuc, Alexandra Herlo, Andreea Nelson Twakor, Luana Alexandrescu, Raluca Dumache · 2024 · International Journal of Molecular Sciences
  34. The microbiome(s) and cancer: know thy neighbor(s)
    Paloma González‐Sánchez, Gina M. DeNicola · 2021 · The Journal of Pathology
  35. Molecules from the Microbiome
    Emilee E. Shine, Jason M. Crawford · 2021 · Annual Review of Biochemistry
  36. Host-Gut Microbiota Metabolic Interactions and Their Role in Precision Diagnosis and Treatment of Gastrointestinal Cancers
    Chunhao Cao, Siran Yue, Aiping Lü, Chao Liang · 2024 · Pharmacological Research
  37. Interactions between microsatellite instability and human gut colonization byEscherichia coliin colorectal cancer
    Johan Gagnière, Virginie Bonnin, Anne‐Sophie Jarrousse, Emilie Cardamone, Allison Agus, Nancy A. Uhrhammer, Pierre Sauvanet, Pierre Déchelotte, Nicolas Barnich, Richard Bonnet et al. · 2017 · Clinical Science
  38. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients
    Hege Smith Tunsjø, Gro Gundersen, Fredrik Rangnes, John Christopher Noone, Alexander Endres, Vahid Bemanian · 2019 · European Journal of Clinical Microbiology & Infectious Diseases
  39. Gut microbiota modulation: a tool for the management of colorectal cancer
    Yan Wang, Hui Li · 2022 · Journal of Translational Medicine
  40. Interactions between diet and gut microbiota in cancer
    Geicho Nakatsu, Natalia Andreeva, Meghan H. MacDonald, Wendy S. Garrett · 2024 · Nature Microbiology
  41. Role of the Microbiota in Colorectal Cancer: Updates on Microbial Associations and Therapeutic Implications
    Olivia I. Coleman, Tiago Nunes · 2016 · BioResearch open access
  42. A small molecule inhibitor prevents gut bacterial genotoxin production
    Matthew R. Volpe, José A. Velilla, Martin Daniel-Ivad, Jenny J. Yao, Alessia Stornetta, Peter W. Villalta, Hsin‐Che Huang, Daniel A. Bachovchin, Silvia Balbo, Rachelle Gaudet et al. · 2022 · Nature Chemical Biology
  43. Contribution of pks+ Escherichia coli (E. coli) to Colon Carcinogenesis
    Mohammad Sadeghi, Denis Mestivier, Iradj Sobhani · 2024 · Microorganisms
  44. From DNA Damage to Cancer Progression: Potential Effects of Cytolethal Distending Toxin
    Yi-Ru Lai, Yu‐Fang Chang, Jason Ma, Cheng‐Hsun Chiu, Ming‐Ling Kuo, Chih‐Ho Lai · 2021 · Frontiers in Immunology
  45. The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal Cancer
    Kaixi Liu, Xinran Yang, Mi Zeng, Yumeng Yuan, Jianhong Sun, Ping He, Jiayu Sun, Qingdong Xie, Xiaolan Chang, Suwei Zhang et al. · 2021 · Disease Markers
  46. An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome
    Shuaiming Jiang, Wenyao Ma, Chenchen Ma, Zeng Zhang, Wanli Zhang, Jiachao Zhang · 2024 · Gut Microbes
  47. Mutational landscape of normal epithelial cells in Lynch Syndrome patients
    Bernard C. H. Lee, Philip S. Robinson, Tim H. H. Coorens, Helen H. N. Yan, Sigurgeir Ólafsson, Henry Lee-Six, Mathijs Arnoud Sanders, Hoi Cheong Siu, James Hewinson, Sarah S K Yue et al. · 2022 · Nature Communications
  48. Endophytic fungi–assisted biomass synthesis of gold, and zinc oxide nanoparticles for increasing antibacterial, and anticancer activities
    S E Hammad, Mahmoud N. El-Rouby, Marwa M. Abdel‐Aziz, Gharieb Saied El-Sayyad, H H Elshikh · 2023 · Biomass Conversion and Biorefinery
  49. Escherichia coli-derived outer membrane vesicles are genotoxic to human enterocyte-like cells
    Peter C. Tyrer, Frank Frizelle, Jacqueline Ilene Keenan · 2014 · Infectious Agents and Cancer
  50. Potential role of Escherichia coli DNA mismatch repair proteins in colon cancer
    Shahanavaj Khan · 2015 · Critical Reviews in Oncology/Hematology
  51. Prostate Microbiota and Prostate Cancer: A New Trend in Treatment
    Bang-Wei Che, Wenjun Zhang, Sheng-Han Xu, Jingju Yin, Jun He, T. Huang, Wei Li, Ying Yu, Kai-Fa Tang · 2021 · Frontiers in Oncology
  52. Cytotoxic necrotizing factor 1 promotes prostate cancer progression through activating the Cdc42–PAK1 axis
    Yaxiu Guo, Zhi‐Song Zhang, Huiting Wei, Jingyu Wang, Junqiang Lv, Kai Zhang, Evan T. Keller, Zhi Yao, Quan Wang · 2017 · The Journal of Pathology
  53. Harness the functions of gut microbiome in tumorigenesis for cancer treatment
    Lee, Mong‐Hong · 2021 · Cancer Communications
  54. E scherichia coli diversity in the lower intestinal tract of humans
    David M. Gordon, Claire Louise O'Brien, Paul Pavli · 2015 · Environmental Microbiology Reports
  55. Uropathogenic E. coli induces DNA damage in the bladder
    Camille V. Chagneau, Clémence Massip, Nadège Bossuet‐Greif, Christophe Fremez, Jean‐Paul Motta, Ayaka Shima, Céline Besson‐Fournier, Pauline Le Faouder, Nicolas Cénac, Marie‐Paule Roth et al. · 2021 · PLoS Pathogens
  56. RETRACTED ARTICLE: Prevalence and pathologic effects of colibactin and cytotoxic necrotizing factor-1 (Cnf 1) in Escherichia coli: experimental and bioinformatics analyses
    Radwa N. Morgan, Sarra E. Saleh, Hala A. Farrag, Mohammad Aboulwafa · 2019 · Gut Pathogens · Retracted
  57. Bacterial signatures and their inflammatory potentials associated with prostate cancer
    Holger Brüggemann, Munir A. Al‐Zeer · 2020 · Apmis
  58. Foes or Friends? Bacteria Enriched in the Tumor Microenvironment of Colorectal Cancer
    Siyang Xu, Wen Yin, Yuling Zhang, Qimei Lv, Yijun Yang, Jin He · 2020 · Cancers
  59. Microbiota in cancer: molecular mechanisms and therapeutic interventions
    Zhou Chen, Defeng Guan, Zhengfeng Wang, Xin Li, Shi Dong, Junjun Huang, Wence Zhou · 2023 · MedComm
  60. Bacterial protein toxins in human cancers
    Francesca Rosadi, Carla Fiorentini, Alessia Fabbri · 2015 · Pathogens and Disease
  61. Intestinal microbiota and colorectal cancer: changes in the intestinal microenvironment and their relation to the disease
    Sandra Aparecida dos Reis, Lisiane Lopes da Conceição, Maria do Carmo Gouveia Pelúzio · 2019 · Journal of Medical Microbiology
  62. Bacterial biofilm in colorectal cancer: What is the real mechanism of action?
    Rasoul Mirzaei, Hamed Mirzaei, Mohammad Yousef Alikhani, Mohammad Sholeh, Mohammad Reza Arabestani, Massoud Saidijam, Sajad Karampoor, Yaghoub Ahmadyousefi, Mohammad Shokri Moghadam, Gholam Reza Irajian et al. · 2020 · Microbial Pathogenesis
  63. Colibactin-Producing Escherichia coli Induce the Formation of Invasive Carcinomas in a Chronic Inflammation-Associated Mouse Model
    Laurène Salesse, Cécily Lucas, My Hanh Thi Hoang, Pierre Sauvanet, Alexandra Rézard, Philip C Rosenstiel, Christelle Damon‐Soubeyrand, Nicolas Barnich, Catherine Godfraind, Guillaume Dalmasso et al. · 2021 · Cancers
  64. Advances in the Study of Bacterial Toxins, Their Roles and Mechanisms in Pathogenesis
    Ciamak Ghazaei · 2022 · Malaysian Journal of Medical Sciences
  65. Genotoxins: The Mechanistic Links between Escherichia coli and Colorectal Cancer
    Ya Wang, Kai Fu · 2023 · Cancers
  66. The microbial genotoxin colibactin exacerbates mismatch repair mutations in colorectal tumors
    Michael W. Dougherty, Rafael Valdés‐Mas, Kevin M. Wernke, Raad Z. Gharaibeh, Ye Yang, Jason Orr Brant, Alberto Riva, Marcus Muehlbauer, Eran Elinav, Jens Puschhof et al. · 2023 · Neoplasia
  67. Molecular Basis of Gut Microbiome-Associated Colorectal Cancer: A Synthetic Perspective
    Alan R. Healy, Seth B. Herzon · 2017 · Journal of the American Chemical Society
  68. Association of Pre-diagnostic Antibody Responses to Escherichia coli and Bacteroides fragilis Toxin Proteins with Colorectal Cancer in a European Cohort
    Julia Butt, Mazda Jenab, Jill Werner, Veronika Fedirko, Elisabete Weiderpass, Christina Catherine Dahm, Anne Marie Tjønneland, Anja Olsen, Marie‐Christine Boutron‐Ruault, Joseph A. Rothwell et al. · 2021 · Gut Microbes
  69. Reversible Senescence of Human Colon Cancer Cells After Blockage of Mitosis/Cytokinesis Caused by the CNF1 Cyclomodulin From Escherichia Coli
    Zhang, Zhen, Aung, Kyaw Min, Uhlin, Bernt Eric, Wai, Sun Nyunt · 2018 · Scientific Reports
  70. The Four Horsemen in Colon Cancer
    Marco Antonio Hernández-Luna, Sergio López-Briones, Rosendo Lurı́a-Pérez · 2019 · Journal of Oncology
  71. Oligosaccharides increase the genotoxic effect of colibactin produced by pks+ Escherichia coli strains
    Manon Oliero, Annie Calvé, Gabriela Fragoso, Thibault Cuisiniere, Roy Hajjar, Ulrich Dobrindt, Manuela M. Santos · 2021 · BMC Cancer
  72. Genetic diversity, phylogroup distribution and virulence gene profile of pks positive Escherichia coli colonizing human intestinal polyps
    Meysam Sarshar, Daniela Scribano, Massimiliano Marazzato, Cecilia Ambrosi, Maria Rita Aprea, Marta Aleandri, Annamaria Pronio, Catia Longhi, Mauro Nicoletti, Carlo Zagaglia et al. · 2017 · Microbial Pathogenesis
  73. Cytotoxic Escherichia coli strains encoding colibactin and cytotoxic necrotizing factor (CNF) colonize laboratory macaques
    Yan Feng, Anthony J. Mannion, Carolyn M. Madden, Alton G. Swennes, Catherine Townes, Charles P. Byrd, Robert P. Marini, James G. Fox · 2017 · Gut Pathogens
  74. Microbiota-Nourishing Immunity: A Guide to Understanding Our Microbial Self
    Yael Litvak, Andreas J. Bäumler · 2019 · Immunity
  75. Exploring the Inflammatory Pathogenesis of Colorectal Cancer
    Ahamed A. Khalyfa, Shil Punatar, Rida Aslam, Alex Yarbrough · 2021 · Diseases
  76. Colibactin-producing Escherichia coli enhance resistance to chemotherapeutic drugs by promoting epithelial to mesenchymal transition and cancer stem cell emergence
    Guillaume Dalmasso, Antony Cougnoux, Tiphanie Faïs, Virginie Bonnin, Benoit Mottet-Auselo, Hang Thi Thu Nguyen, Pierre Sauvanet, Nicolas Barnich, Marine Jary, Denis Pezet et al. · 2024 · Gut Microbes
  77. Sensing Bacterial-Induced DNA Damaging Effects via Natural Killer Group 2 Member D Immune Receptor: From Dysbiosis to Autoimmunity and Carcinogenesis
    Jorge Luis Espinoza, Mika Minami · 2018 · Frontiers in Immunology
  78. ClbR Is the Key Transcriptional Activator of Colibactin Gene Expression in Escherichia coli
    Alexander Wallenstein, Nadine Rehm, Marina Brinkmann, Martina Selle, Nadège Bossuet‐Greif, Daniel Sauer, Boyke Bunk, Cathrin Spröer, Haleluya Tesfaye Wami, Stefan Homburg et al. · 2020 · mSphere
  79. Escherichia coli and Colorectal Cancer: Unfolding the Enigmatic Relationship
    Mohammad Ahangarzadeh Rezaee, Roghayeh Nouri, Alka Hasani, Kourosh Masnadi Shirazi, Mohammad Reza Alivand, Bita Sepehri, Simin Sotoodeh, Fatemeh Hemmati · 2021 · Current Pharmaceutical Biotechnology
  80. Cancer-Associated Microbiota: From Mechanisms of Disease Causation to Microbiota-Centric Anti-Cancer Approaches
    Priyankar Dey, Saumya Ray Chaudhuri · 2022 · Biology
  81. Prevalence, Abundance, and Virulence of Adherent-Invasive Escherichia coli in Ulcerative Colitis, Colorectal Cancer, and Coeliac Disease
    Mireia López‐Siles, Carla Camprubí-Font, Eva M. Gómez del Pulgar, M Sàbat, David Busquets, Yolanda Sanz, Margarita Martínez-Medina · 2022 · Frontiers in Immunology
  82. The pks island: a bacterial Swiss army knife? Colibactin: beyond DNA damage and cancer
    Camille V. Chagneau, Delphine Payros, Min Tang-Fichaux, Frédéric Auvray, Jean‐Philippe Nougayrède, Éric Oswald · 2022 · Trends in Microbiology
  83. Infection with genotoxin‐producing Salmonella enterica synergises with loss of the tumour suppressor APC in promoting genomic instability via the PI3K pathway in colonic epithelial cells
    Océane C. B. Martin, Anna Bergonzini, Federica D’Amico, Puran Chen, Jerry W. Shay, Jacques Dupuy, Mattias Svensson, Maria Grazia Masucci, Teresa Frisan · 2019 · Cellular Microbiology
  84. Understanding the cross-talk between human microbiota and gastrointestinal cancer for developing potential diagnostic and prognostic biomarkers
    Sheetal Kashyap, Soumya Pal, Gourav Chandan, Vipin Saini, Sasanka Chakrabarti, Neeraj Kumar Saini, Amit Mittal, Vijay Kumar Thakur, Adesh Kumar Saini, Reena V. Saini · 2021 · Seminars in Cancer Biology
  85. Colon Tumors in Enterotoxigenic Bacteroides fragilis (ETBF)-Colonized Mice Do Not Display a Unique Mutational Signature but Instead Possess Host-Dependent Alterations in the APC Gene
    Jawara Allen, Axel Rosendahl Huber, Cayetano Pleguezuelos‐Manzano, Jens Puschhof, Shaoguang Wu, Xinqun Wu, Charelle Boot, Aurelia Saftien, Heather M. O’Hagan, Hao Wang et al. · 2022 · Microbiology Spectrum
  86. New Insights into the Relationship between Gut Microbiota and Radiotherapy for Cancer
    Zhipeng Li, Xiyang Ke, Zuo Dan, Zhicheng Wang, Fang Fang, Bo Li · 2022 · Nutrients
  87. Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?
    Samira Tarashi, Seyed Davar Siadat, Sara Ahmadi Badi, Mohammad Reza Zali, Roberto Biassoni, Mirco Ponzoni, Arfa Moshiri · 2019 · Microorganisms
  88. Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis
    Matthew Silbergleit, Adrian A. Vasquez, Carol J. Miller, Jun Sun, Ikuko Kato · 2020 · Progress in molecular biology and translational science
  89. Gut Enterobacteriaceae and uraemic toxins - Perpetrators for ageing
    Seenivasan Boopathi, R.M. Saravana Kumar, P. Snega Priya, B. Haridevamuthu, S.P. Ramya Ranjan Nayak, Laura Chulenbayeva, Almagul R. Kushugulova, Jesu Arockiaraj · 2023 · Experimental Gerontology
  90. The Cytotoxic Necrotizing Factor 1 from E. Coli: A Janus Toxin Playing with Cancer Regulators
    Alessia Fabbri, Sara Travaglione, Giulia Ballan, Stefano Loizzo, Carla Fiorentini · 2013 · Toxins
  91. Synthesis and reactivity of precolibactin 886
    Alan R. Healy, Kevin M. Wernke, Chung Sub Kim, Nicholas R. Lees, Jason M. Crawford, Seth B. Herzon · 2019 · Nature Chemistry
  92. Colorectal cancer: The epigenetic role of microbiome
    Hussein Sabit, Emre Çevik, Hüseyin Tombuloğlu · 2019 · World Journal of Clinical Cases
  93. Gut Epithelial Metabolism as a Key Driver of Intestinal Dysbiosis Associated with Noncommunicable Diseases
    Catherine D. Shelton, Mariana Xavier Byndloss · 2020 · Infection and Immunity
  94. A One Health Perspective for Defining and Deciphering Escherichia coli Pathogenic Potential in Multiple Hosts
    Alexis García, James G. Fox · 2021 · Comparative Medicine
  95. Escherichia coli small molecule metabolism at the host–microorganism interface
    Alexandra Gatsios, Chung Sub Kim, Jason M. Crawford · 2021 · Nature Chemical Biology
  96. Therapeutic potential of melatonin in colorectal cancer: Focus on lipid metabolism and gut microbiota
    Pan, Shijia, Guo, Yuan, Hong, Fan, Xu, Pengfei, Zhai, Yonggong · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  97. The gut microbiome and melanoma: A review
    Stanislau Makaranka, Freya Scutt, Mikaela Frixou, Katherine E Wensley, Ravi Sharma, Jennifer Greenhowe · 2022 · Experimental Dermatology
  98. Dietary fibre counters the oncogenic potential of colibactin-producing Escherichia coli in colorectal cancer
    Bhupesh Kumar Thakur, Yann Malaisé, Saurav Roy Choudhury, Anna Neustaeter, Williams Turpin, Catherine Streutker, Julia K. Copeland, Erin O. Y. Wong, William Wiley Navarre, David S. Guttman et al. · 2025 · Nature Microbiology
  99. The Role of Microbiota-Derived Metabolites in Colorectal Cancer
    Coco Duizer, Marcel R. de Zoete · 2023 · International Journal of Molecular Sciences
  100. Hypervirulent Klebsiella pneumoniae employs genomic island encoded toxins against bacterial competitors in the gut
    Yi Han Tan, Patricio Arros, Camilo Berríos-Pastén, Indrik Wijaya, Wilson H. W. Chu, Yahua Chen, Guoxiang Cheam, Ahmad Nazri Mohamed Naim, Andrés E. Marcoleta, Aarthi Ravikrishnan et al. · 2024 · The ISME Journal